DEXMDERM Trademark

Trademark Overview

On Wednesday, May 20, 2015, a trademark application was filed for DEXMDERM with the United States Patent and Trademark Office. The USPTO has given the DEXMDERM trademark a serial number of 86636721. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 8, 2019. This trademark is owned by Teikoku Pharma USA, Inc.. The DEXMDERM trademark is filed in the Pharmaceutical Products category with the following description:

Transdermal patches for use in the treatment of attention deficit hyperactivity disorder, anxiety insomnia, or withdrawal syndromes; transdermal patches for use in the management of pain; and transdermal patches for use in providing sedation; Pharmaceutical preparations, namely, topical preparations for use in the treatment of attention deficit hyperactivity disorder; Pharmaceutical preparations, namely, topical preparations for use in the treatment of anxiety; Pharmaceutical preparations, namely, topical preparations for use in the treatment of insomnia; Pharmaceutical preparations, namely, topical preparations for use in the treatment of withdrawal syndromes; topical preparations for use in the management of pain; and topical preparations for use in providing sedation
dexmderm

General Information

Serial Number86636721
Word MarkDEXMDERM
Filing DateWednesday, May 20, 2015
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 8, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 12, 2016

Trademark Statements

Goods and ServicesTransdermal patches for use in the treatment of attention deficit hyperactivity disorder, anxiety insomnia, or withdrawal syndromes; transdermal patches for use in the management of pain; and transdermal patches for use in providing sedation; Pharmaceutical preparations, namely, topical preparations for use in the treatment of attention deficit hyperactivity disorder; Pharmaceutical preparations, namely, topical preparations for use in the treatment of anxiety; Pharmaceutical preparations, namely, topical preparations for use in the treatment of insomnia; Pharmaceutical preparations, namely, topical preparations for use in the treatment of withdrawal syndromes; topical preparations for use in the management of pain; and topical preparations for use in providing sedation

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, May 29, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTeikoku Pharma USA, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Jose, CA 951311711
Party NameTeikoku Pharma USA, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Jose, CA 951311711

Trademark Events

Event DateEvent Description
Monday, April 8, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, April 8, 2019ABANDONMENT - NO USE STATEMENT FILED
Friday, September 14, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 13, 2018EXTENSION 5 GRANTED
Wednesday, September 5, 2018EXTENSION 5 FILED
Thursday, September 13, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, September 5, 2018TEAS EXTENSION RECEIVED
Thursday, March 8, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 6, 2018EXTENSION 4 GRANTED
Tuesday, March 6, 2018EXTENSION 4 FILED
Tuesday, March 6, 2018TEAS EXTENSION RECEIVED
Tuesday, September 5, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 1, 2017EXTENSION 3 GRANTED
Friday, September 1, 2017EXTENSION 3 FILED
Friday, September 1, 2017TEAS EXTENSION RECEIVED
Wednesday, March 8, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 6, 2017EXTENSION 2 GRANTED
Monday, March 6, 2017EXTENSION 2 FILED
Monday, March 6, 2017TEAS EXTENSION RECEIVED
Monday, January 9, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, September 8, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 6, 2016EXTENSION 1 GRANTED
Tuesday, September 6, 2016EXTENSION 1 FILED
Tuesday, September 6, 2016TEAS EXTENSION RECEIVED
Tuesday, March 8, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 12, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 12, 2016PUBLISHED FOR OPPOSITION
Thursday, December 24, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, November 11, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 27, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 27, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 27, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, September 1, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, September 1, 2015NON-FINAL ACTION E-MAILED
Tuesday, September 1, 2015NON-FINAL ACTION WRITTEN
Monday, August 31, 2015ASSIGNED TO EXAMINER
Friday, May 29, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, May 23, 2015NEW APPLICATION ENTERED IN TRAM

Related Keywords

dexmderm preparations topical treatment pharmaceutical namely patches transdermal pain management sedation